Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)

STOCKHOLM – July 28, 2022 – Inify Laboratories AB (publ) hereby invites its shareholders to en Extraordinary General Meeting on August 30th, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact the companys CFO Ann-Charlotte Linderoth at e-mail: ann-charlotte.linderoth@inify.com for any questions regarding the EGM.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within histopathology. Fully digital, standardized and AI- supported workflow is applied to optimize quality and response times, initially for prostate cancer. The concept is scalable and extendible to other diagnosis. The company origins from ContextVision and became independent in February 2022. The company is based in Sweden and listed on Euronext Growth Oslo under the ticker INIFY.